Alinidine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlinidine
Drug Alias Namealinidinum烯丙尼定alinidina烯丙可乐宁alinidine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsHypertensionAngina PectorisHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsHypertensionAngina PectorisHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia